Zobrazeno 1 - 10
of 91
pro vyhledávání: '"Marta A. Miyares"'
Publikováno v:
Scientia Marina, Vol 80, Iss S1, Pp 11-14 (2016)
Externí odkaz:
https://doaj.org/article/752132e7f1e84274a5e5c2162980a600
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Scientia Marina, Vol 80, Iss S1, Pp 11-14 (2016)
Scientia Marina; Vol. 80 No. S1 (2016); 11-14
Scientia Marina; Vol. 80 Núm. S1 (2016); 11-14
Scientia Marina
Consejo Superior de Investigaciones Científicas (CSIC)
Scientia Marina; Vol. 80 No. S1 (2016); 11-14
Scientia Marina; Vol. 80 Núm. S1 (2016); 11-14
Scientia Marina
Consejo Superior de Investigaciones Científicas (CSIC)
Biography Marta Estrada Miyares for the special volume: Planet Ocean. Scientia Marina 80(Suppl.1) 2016.-- 4 pages, 5 figures
Autor:
Joseph E Mazur, Melissa E Badowski, Simon W. Lam, Lucas T Schulz, Sarah M Michienzi, Marta A. Miyares
Publikováno v:
Hospital Pharmacy. 52:33-43
Research offers an opportunity for investigators to explore unanswered questions, highlight best practices, and engage in collaboration. Clinical research can engage health care professionals to identify treatments or procedures to enhance patient ca
Publikováno v:
American Journal of Health-System Pharmacy. 72:1623-1629
Purpose The safety and efficacy of dual antiplatelet therapy (DAPT) with aspirin and clopidogrel in the setting of secondary stroke prevention are reviewed. Summary Antiplatelet therapy has been shown to reduce the risk of numerous vascular events, e
Autor:
Maria Padron, Marta A. Miyares
Publikováno v:
Journal of Pharmacy Practice. 28:93-98
Pharmacist-directed anticoagulation management services (AMSs) have been shown to significantly lower anticoagulation-related mortality, length of hospital stay, bleeding complications, blood transfusion requirements, and cost of therapy. AMSs are on
Autor:
Kyle A. Davis, Marta A. Miyares
Publikováno v:
Preventing Chronic Disease
To the Editor: We applaud Oldenburg and colleagues for the successful implementation of a community-based intervention to curtail cardiovascular disease (CVD) (1). The authors promote the increased use of aspirin for primary prevention (the aim of wh
Autor:
Marta A. Miyares
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 73(10)
Bayat and colleagues[1][1] should be applauded for their research on the early diagnosis of heparin-induced thrombocytopenia (HIT), in which they found that the combination of optical density (OD) values for antiheparin–platelet factor 4 (anti-PF4)
Publikováno v:
Journal of pharmacy practice. 28(6)
Objective: To evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of t
Publikováno v:
Journal of Pharmacy Practice. 26:438-441
A pharmacist-managed deep vein thrombosis (DVT) treatment program was put into operation at Jackson Memorial Hospital in Miami, Florida to provide appropriate transition of care to the outpatient setting for patients diagnosed with DVT. A postgraduat